𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reply to Palacios et al., “ERBB2 and MYC alterations in BRCA1- and BRCA2-associated cancers”

✍ Scribed by Robert B. Jenkins; Camilo Adem; Fergus Couch; Lynn C. Hartmann

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
32 KB
Volume
42
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ERBB2, TBX2, RPS6KB1, and MYC alteration
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers
✍ Camilo Adem; Cheryl L. Soderberg; Kari Hafner; Carol Reynolds; Jeffrey M. Slezak 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 1 views

Breast cancer risk is greatly increased in women who carry mutations in the BRCA1 or BRCA2 genes. Because breast cancer initiation is different between BRCA1/2 mutation carriers and women who do not carry mutations, it is possible that the mechanism of breast cancer progression is also different. Hi

Somatic genetic alterations in BRCA2-ass
Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer
✍ Mika Tirkkonen; Tommi Kainu; Niklas Loman; Óskar T. Jóhannsson; Håkan Olsson; Ró 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 2 views

The genetic changes underlying the development and progression of male breast cancer are poorly understood. Germline BRCA2 mutations account for a significant part of male breast cancer, but the majority of patients lack a known inherited predisposition. We recently demonstrated that the progression

Germline mutations of the BRCA1-associat
Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations
✍ Chiara Ghimenti; Elisa Sensi; Silvano Presciuttini; Isa Maura Brunetti; PierFran 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 3 views

## Abstract BARD1 (BRCA1‐associated RING domain) was identified by yeast two‐hybrid screening as a protein interacting with BRCA1. Somatic and germline mutations of __BARD1__ have been detected in sporadic breast, ovarian, and endometrial cancers. The present study represents the first description